Every one of those 1 sits in a single category, clinical-trial. Of the tracked stories, 1 of 1 also mention Genomics Aotearoa, the most common co-covered peer. We currently track 1 Biotech story that mention Māori and Pacific populations, all published on March 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Māori and Pacific populations
Every one of those 1 sits in a single category, clinical-trial. Of the tracked stories, 1 of 1 also mention Genomics Aotearoa, the most common co-covered peer. We currently track 1 Biotech story that mention Māori and Pacific populations, all published on March 18, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Māori and Pacific populations. Shared-story counts are live from our verified record — not editorial picks.
New Zealand has initiated a major genomic medicine trial designed to provide locally-based genetic sequencing for patients battling cancer and rare diseases. By repatriating diagnostic capabilities, the program aims to accelerate treatment timelines and improve health equity across the country's diverse populations.
Māori and Pacific populations is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.